Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.34
0.0050.37%
Last update: Dec 18, 10:42 AM
Comments
Loading...
Zentalis Pharma (ZNTL) Stock Price, Quote, News & History
ZNTLNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Zentalis Pharma (ZNTL) stock?
You can purchase shares of Zentalis Pharma (NASDAQ:ZNTL) through any online brokerage.
Who are Zentalis Pharma (ZNTL) competitors?
Other companies in Zentalis Pharma’s space includes: Macrogenics Inc (NASDAQ:MGNX), Outlook Therapeutics Inc (NASDAQ:OTLK), Tharimmune Inc (NASDAQ:THAR), Anixa Biosciences Inc (NASDAQ:ANIX) and Fortress Biotech Inc (NASDAQ:FBIO).
What is the forecast, or price target, for Zentalis Pharma (ZNTL) stock?
Zentalis Pharma has a consensus price target of $14.32.
What is the current price for Zentalis Pharma (ZNTL)?
The stock price for Zentalis Pharma (NASDAQ: ZNTL) is $1.345 last updated December 18, 2025 at 10:42 AM EST.
Does Zentalis Pharma (ZNTL) pay a dividend?
There are no upcoming dividends for Zentalis Pharma.
When is Zentalis Pharma (NASDAQ:ZNTL) reporting earnings?
Zentalis Pharma does not have any upcoming earnings scheduled.
Is Zentalis Pharma (ZNTL) going to split?
There is no upcoming split for Zentalis Pharma.
What sector and industry does Zentalis Pharma (ZNTL) operate in?
Zentalis Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
